Next |
home / stock / vir / vir message board
Subject | By | Source | When |
---|---|---|---|
48w VIR-2219 +peg-IFN>31% HBs seroconverion: | DewDiligence | investorshub | 11/06/2022 11:32:58 PM |
$VIR EASL presentations: | DewDiligence | investorshub | 06/25/2022 7:50:22 PM |
$VIR HBV webcast slides: | DewDiligence | investorshub | 04/27/2022 4:03:27 PM |
$VIR -14% on amended Sotrovimab EUA due to | DewDiligence | investorshub | 03/25/2022 8:28:36 PM |
$VIR 4Q21 results: | DewDiligence | investorshub | 02/24/2022 9:25:27 PM |
VIRs 2022 HBV newsflow: | DewDiligence | investorshub | 02/24/2022 9:23:46 PM |
Up so far on another Biotech down day | rwwest | investorshub | 01/21/2022 5:45:54 PM |
VIR slide set from $JPM: | DewDiligence | investorshub | 01/11/2022 6:45:08 PM |
VIR/$GILD start phase-2 trial testing quadruple regimen of | DewDiligence | investorshub | 12/09/2021 3:06:10 PM |
Loaded again. After omicron news all weekend this | HokieHead | investorshub | 12/03/2021 4:58:52 PM |
In $46, omicron play. | HokieHead | investorshub | 12/02/2021 8:19:15 PM |
$VIR starts HBV combination trial of $VIR-2218 and $VIR-3434: | DewDiligence | investorshub | 07/15/2021 4:34:13 PM |
VIR -6% on VIR-2218 and VIR-3434 monotherapy data | DewDiligence | investorshub | 06/25/2021 2:31:45 PM |
profound efficacy. Vir Biotechnology and $GSK plan to | level42 | investorshub | 03/11/2021 10:35:51 PM |
Too high too fast. Very typical price movement. | interloper | investorshub | 01/29/2021 6:44:43 PM |
why is $VIR coming back down??? | dealerschool2006 | investorshub | 01/28/2021 4:29:24 PM |
Huge disappointment. | rtrstock | investorshub | 01/27/2021 8:40:09 PM |
Two New Rockships Taking Off After$ VIR Behold!$ FNMA | CatBirdSeat | investorshub | 01/27/2021 5:12:58 PM |
I Should have sold at 140.00 | rtrstock | investorshub | 01/27/2021 4:58:34 PM |
Full of crap haha | Srhogan1984 | investorshub | 01/27/2021 2:55:41 AM |
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, 2024, on August 1, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on August 1, 2024. Financial results will ...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
2024-07-08 10:47:03 ET BITX (BITX) BITX is trading DOWN for the last 4 days, and it at trading at $27.48 with volume of 3,908,355 and a one day change of $-0.37 (-1.33%). BITX has a 52-week low of 0.00 and a 52-week high of $0.00. The business's 50-day moving average price is $45.40...